Analytic Investors’s Amgen AMGN Stock Holding History

Analytic Investors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$87.7M	Buy	525,597 +269,253	+105%	+$45.5M	0.98%	28
2016 Q2	$39M	Buy	256,344 +79,102	+45%	+$12.3M	0.46%	63
2016 Q1	$26.6M	Buy	177,242 +40,940	+30%	+$6.08M	0.32%	82
2015 Q4	$22.1M	Sell	136,302 -24,130	-15%	-$3.79M	0.28%	90
2015 Q3	$22.2M	Sell	160,432 -26,399	-14%	-$4.16M	0.3%	83
2015 Q2	$28.7M	Sell	186,831 -9,427	-5%	-$1.51M	0.4%	66
2015 Q1	$31.4M	Buy	196,258 +189,061	+2,627%	+$29.8M	0.43%	62
2014 Q4	$1.15M	Buy	+7,197	New	+$1.12M	0.02%	331
2014 Q3	–	Sell	-75,760	Closed	-$8.97M	–	590
2014 Q2	$8.97M	Sell	75,760 -11,877	-14%	-$1.37M	0.15%	136
2014 Q1	$10.8M	Sell	87,637 -63,339	-42%	-$7.68M	0.16%	140
2013 Q4	$17.2M	Sell	150,976 -76,491	-34%	-$8.7M	0.29%	99
2013 Q3	$25.5M	Sell	227,467 -981,850	-81%	-$106M	0.41%	76
2013 Q2	$119M	Buy	+1,209,317	New	+$125M	1.98%	3

Other funds holding AMGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Analytic Investors's AMGN Position: Q3 2016 in Review

Analytic Investors increased its Amgen (AMGN) stake by 105% in Q3 2016, buying an estimated $45.5M and bringing the position to 525,597 shares worth $87.7M. The position accounts for 0.98% of the portfolio, ranked #28.

Analytic Investors first reported a position in AMGN in Q2 2013 and has held it in 13 quarters since. The position peaked at $119M in Q2 2013. 1,517 funds tracked by Wall St. Rank hold AMGN as of Q3 2016.

Analytic Investors held 525,597 shares of Amgen worth $87.7M as of Q3 2016.
Analytic Investors bought 269,253 Amgen shares in Q3 2016, an estimated $45.5M.
Amgen made up 0.98% of Analytic Investors's portfolio in Q3 2016, its #28 holding.
Analytic Investors first reported a position in Amgen in Q2 2013 and has held it in 13 quarters since.
Analytic Investors's Amgen position peaked at $119M in Q2 2013.
1,517 funds tracked by Wall St. Rank held Amgen as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.